Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption

NCT05232942 · clinicaltrials.gov ↗
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hospital Clínico Universitario de Valladolid